GTCR’s Zentiva buyout gets EU clearance
MLex Summary: The European Commission has allowed US private-equity firm GTCR to acquire Czech generic drugmaker Zentiva, with no conditions. The deal was announced last September, and GTCR said it expected...To view the full article, register now.
Already a subscriber? Click here to view full article